These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25784383)

  • 1. Conventional medical therapy for osteoarthritis: current state of the evidence.
    Gelber AC
    Curr Opin Rheumatol; 2015 May; 27(3):312-7. PubMed ID: 25784383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoarthritis year in review 2015: clinical.
    Sharma L
    Osteoarthritis Cartilage; 2016 Jan; 24(1):36-48. PubMed ID: 26707991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.
    Magnano MD; Chakravarty EF; Broudy C; Chung L; Kelman A; Hillygus J; Genovese MC
    J Rheumatol; 2007 Jun; 34(6):1323-7. PubMed ID: 17516620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Slow-acting anti-rheumatic agents: recent developments].
    Van Linthoudt D; Gerster JC
    Rev Med Suisse Romande; 2004 Sep; 124(9):565-7. PubMed ID: 15552752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic drugs as analgesics for the management of osteoarthritis.
    Dimitroulas T; Lambe T; Klocke R; Kitas GD; Duarte RV
    Semin Arthritis Rheum; 2017 Jun; 46(6):687-691. PubMed ID: 28063649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment.
    Dimitroulas T; Duarte RV; Behura A; Kitas GD; Raphael JH
    Semin Arthritis Rheum; 2014 Oct; 44(2):145-54. PubMed ID: 24928208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of glucosamine and chondroitin in persons with osteoarthritis.
    Sherman AL; Ojeda-Correal G; Mena J
    PM R; 2012 May; 4(5 Suppl):S110-6. PubMed ID: 22632689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medication a complement to other forms of pain management in osteoarthritis].
    Petersson I
    Lakartidningen; 2002 Nov; 99(46):4647-50. PubMed ID: 12486970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoarthritis: a review of treatment options.
    Seed SM; Dunican KC; Lynch AM
    Geriatrics; 2009 Oct; 64(10):20-9. PubMed ID: 20726384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)].
    Aubry-Rozier B
    Rev Med Suisse; 2012 Mar; 8(332):571-2, 574, 576. PubMed ID: 22455150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium ranelate: ready for clinical use as disease-modifying osteoarthritis drug?
    Lafeber FP; van Laar JM
    Ann Rheum Dis; 2013 Feb; 72(2):157-61. PubMed ID: 23292449
    [No Abstract]   [Full Text] [Related]  

  • 12. New treatments for osteoarthritis.
    Smelter E; Hochberg MC
    Curr Opin Rheumatol; 2013 May; 25(3):310-6. PubMed ID: 23425965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current role of glucosamine in the treatment of osteoarthritis.
    Reginster JY; Bruyere O; Neuprez A
    Rheumatology (Oxford); 2007 May; 46(5):731-5. PubMed ID: 17401134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodology of clinical trials in hand osteoarthritis. Issues and proposals.
    Maheu E; Dreiser RL; Lequesne M
    Rev Rhum Engl Ed; 1995 Jun; 62(6 Suppl 1):55S-62S. PubMed ID: 7583183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium.
    Pelletier JP; Kapoor M; Fahmi H; Lajeunesse D; Blesius A; Maillet J; Martel-Pelletier J
    Ann Rheum Dis; 2013 Feb; 72(2):250-7. PubMed ID: 23065732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future therapeutics for osteoarthritis.
    Martel-Pelletier J; Wildi LM; Pelletier JP
    Bone; 2012 Aug; 51(2):297-311. PubMed ID: 22037003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on osteoarthritis therapeutics.
    Hogenmiller MS; Lozada CJ
    Curr Opin Rheumatol; 2006 May; 18(3):256-60. PubMed ID: 16582688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?
    Hochberg M; Chevalier X; Henrotin Y; Hunter DJ; Uebelhart D
    Curr Med Res Opin; 2013 Mar; 29(3):259-67. PubMed ID: 23186102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of osteoarthritis in hypertensive patients.
    Mackenzie IS; MacDonald TM
    Expert Opin Pharmacother; 2010 Feb; 11(3):393-403. PubMed ID: 20059368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targeted anti-cytokine therapies for osteoarthritis].
    Chevalier X; Mugnier B; Bouvenot G
    Bull Acad Natl Med; 2006 Oct; 190(7):1411-20; discussion 1420, 1475-7. PubMed ID: 17450677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.